What Is Integrated Prenatal Screening?
Learn what integrated prenatal screening is, a combined first and second trimester test for chromosomal abnormalities. US guide 2026. Understand accuracy, timing, and next steps.
Integrated prenatal screening (IPS) is a two-step prenatal test that combines results from first-trimester blood work and a nuchal translucency ultrasound with second-trimester blood analysis (the quad screen) to produce a single, highly accurate risk score for Down syndrome (trisomy 21), trisomy 18, and open neural tube defects. Unlike standalone first-trimester screening or the quad screen alone, IPS uses all available markers to maximize detection while minimizing false positives. This type of screening is non-invasive and poses no risk to the pregnancy, but it is not diagnostic—abnormal results require follow-up with chorionic villus sampling or amniocentesis. In the United States, integrated screening is typically offered to women who begin prenatal care early enough to complete both phases.
How Integrated Prenatal Screening Works
The process unfolds over two visits, with all results combined into a final risk estimate.
First-Trimester Component (Weeks 10–13)
You undergo a blood draw to measure pregnancy-associated plasma protein A (PAPP-A) and human chorionic gonadotropin (hCG). At the same appointment, a nuchal translucency ultrasound evaluates fluid behind the fetus’s neck. These markers are analyzed alongside maternal age and gestational age.
Second-Trimester Component (Weeks 15–20)
A second blood draw measures four substances: alpha-fetoprotein (AFP), hCG, estriol, and inhibin A (the quad screen). This step also screens for open neural tube defects, which first-trimester markers cannot detect.
Risk Calculation
A proprietary software algorithm combines all first- and second-trimester data into a single integrated risk score. Because more information is used, integrated screening achieves a Down syndrome detection rate of roughly 94–96% with a false-positive rate of about 5%—significantly better than either trimester alone.
Integrated Screening vs. Other Prenatal Tests
Understanding how IPS compares to other options helps you make an informed choice. Below is a quick comparison of common prenatal screening and diagnostic tests available in the US.
| Test Type | Timing | Detection Rate (T21) | Invasive? |
|---|---|---|---|
| Integrated Prenatal Screening | First + second trimester | ~94–96% | No |
| First-Trimester Screening | Weeks 10–13 | ~82–87% | No |
| Quad Screen | Weeks 15–20 | ~79–81% | No |
| NIPT (cell-free DNA) | From week 10 | >99% | No |
| Chorionic Villus Sampling (CVS) | Weeks 10–13 | >99% | Yes |
| Amniocentesis | Weeks 15–20 | >99% | Yes |
Note: NIPT uses cell-free DNA and can also screen for sex chromosome conditions, but it does not assess neural tube defects. Integrated screening covers both chromosomal and neural tube anomalies. Carrier screening is a separate blood test that looks for recessive genetic conditions, often offered alongside integrated screening.
Who Should Consider Integrated Prenatal Screening?
Integrated screening is a good fit for many pregnant individuals, especially those who:
- Are 35 years or older at delivery (advanced maternal age)
- Have a family history of Down syndrome or other chromosomal abnormalities
- Had a previous child with a chromosomal condition
- Want a broad, non-invasive screen that includes neural tube defect detection
- Begin prenatal care before 13 weeks and can commit to two blood draws
Your obstetrician or genetic counselor can help determine if IPS is appropriate based on your medical history and preferences.
Advantages and Limitations
Advantages
IPS offers the highest detection rate among conventional serum screening methods. Because it uses all available markers, fewer pregnancies are falsely labeled as high-risk, reducing unnecessary anxiety and invasive follow-up procedures. It also screens for neural tube defects, which NIPT does not cover.
Limitations
The main drawback is the need for two appointments, which can be logistically challenging. Results are not available until after the second blood draw, around week 16–20. Additionally, integrated screening is not diagnostic—a positive result must be confirmed by CVS or amniocentesis. It also cannot detect all genetic conditions; carrier screening or NIPT may be recommended for additional information.
Next Steps After Integrated Screening
If your integrated screening result is low-risk, no further testing is usually needed. If the result is high-risk, your provider will likely refer you to a genetic counselor to discuss diagnostic options like chorionic villus sampling or amniocentesis. A genetic counselor can also review your family history and coordinate any additional carrier screening or NIPT if desired. Remember, screening only estimates risk—it does not diagnose a condition.
You can now order a comprehensive prenatal screening panel online and get results quickly. order a prenatal screening panel online
Ready to get screened? Order a prenatal carrier screening panel online through our partner and visit a local lab near you.
Order Prenatal Carrier ScreeningAbout PrenatalScreenings
PrenatalScreenings.com is a local lab information directory. We do not provide medical advice, diagnose conditions, or interpret test results. Always consult a qualified healthcare provider for personal medical guidance.